EWA
PROK icon

EP Wealth Advisors’s ProKidney PROK Stock Holding History

EP Wealth Advisors’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.4K Buy
+10,000
New +$18.3K ﹤0.01% 1708

Other funds holding PROK

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $542M AUM 206.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

EP Wealth Advisors's PROK Position: Q2 2026 in Review

EP Wealth Advisors opened a new position in ProKidney (PROK) in Q2 2026: 10,000 shares worth $20.4K. The stake represents ﹤0.01% of the portfolio and ranks #1708 among its holdings.

71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • EP Wealth Advisors held 10,000 shares of ProKidney worth $20.4K as of Q2 2026.
  • ProKidney was a new EP Wealth Advisors position in Q2 2026.
  • ProKidney made up ﹤0.01% of EP Wealth Advisors's portfolio in Q2 2026, its #1708 holding.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on EP Wealth Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.